Rapid Dose Therapeutics Corp. (CSE:DOSE)
Canada flag Canada · Delayed Price · Currency is CAD
0.1050
+0.0150 (16.67%)
Jun 30, 2026, 3:37 PM EST

Rapid Dose Therapeutics Revenue

In the fiscal year ending February 28, 2026, Rapid Dose Therapeutics had annual revenue of 2.77M CAD with 33.00% growth. Rapid Dose Therapeutics had revenue of 660.52K in the quarter ending February 28, 2026, a decrease of -1.21%.

Revenue
2.77M
Revenue Growth
+33.00%
P/S Ratio
5.17
Revenue / Employee
n/a
Employees
n/a
Market Cap
14.33M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Feb 28, 20262.77M688.14K33.00%
Feb 28, 20252.09M1.06M104.34%
Feb 29, 20241.02M302.13K42.06%
Feb 28, 2023718.30K-1.03M-59.00%
Feb 28, 20221.75M996.72K131.98%
Feb 28, 2021 Pro Pro Pro
Feb 29, 2020 Pro Pro Pro
Feb 28, 2019 Pro Pro Pro
Feb 28, 2018 Pro Pro Pro